P. Perik

发表

The relation between soluble apoptotic proteins and subclinical cardiotoxicity in adjuvant-treated breast cancer patients.

E. D. de Vries, J. Gietema, W. T. van der Graaf, 2006, Anticancer research.

125 9 THE ROLE OF SOLUBLE APOPTOTIC PROTEINS IN DETECTING ANTHRACYCLINE CARDIOTOXICITY

D. J. Veldhuisen, J. Gietema, F. Boomsma, 2005 .

Molecular imaging in metastatic breast cancer

G. Hospers, E. Vries, W. Graaf, 2007 .

Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors

E. D. de Vries, J. Gietema, W. T. van der Graaf, 2006, Acta oncologica.

8 CIRCULATING APOPTOSIS-RELATED PARAMETERS ARE INCREASED IN LONG-TERM DISEASE-FREE BREAST CANCER SURVIVORS AFTER ANTHRACYCLINE CHEMOTHERAPY AND CHEST WALL IRRADIATION

D. J. Veldhuisen, J. Gietema, F. Boomsma, 2005 .

Results of plasma N-terminal pro B-type natriuretic peptide and cardiac troponin monitoring in GIST patients do not support the existence of imatinib-induced cardiotoxicity.

J. Verweij, B. Rikhof, J. Gietema, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Molecular imaging: what can be used today

A. van Waarde, E. de Vries, M. L. Lub-de Hooge, 2005, Cancer imaging : the official publication of the International Cancer Imaging Society.

Preclinical characterisation of 111In‐DTPA‐trastuzumab

J. Bart, J. Kosterink, L. Tran, 2004, British journal of pharmacology.

43 3 EXPERIMENTAL ANIMAL MODEL FOR ANTHRACYCLINE-INDUCED HEART FAILURE

D. J. Veldhuisen, E. Vries, M. Berg, 2005 .

83 6 SERUM HER 2 LEVELS ARE INCREASED IN PATIENTS WITH CHRONIC HEART FAILURE

D. J. Veldhuisen, J. Gietema, D. Sleijfer, 2005 .

Experimental animal model for anthracycline‐induced heart failure

D. J. Veldhuisen, E. Vries, M. Berg, 2004, European journal of heart failure.

47 4 PRECLINICAL CHARACTERIZATION OF 111 IN-DTPA-TRASTUZUMAB

J. Bart, J. Kosterink, L. Tran, 2005 .

5 111 IN-LABELED TRASTUZUMAB SCINTIGRAPHY IN PATIENTS WITH HER 2-POSITIVE METASTATIC BREAST CANCER

D. J. Veldhuisen, J. Kosterink, J. Gietema, 2005 .

Circulating apoptosis-related proteins in long-term disease free breast cancer survivors.

E. D. de Vries, J. Gietema, W. T. van der Graaf, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors.

E. D. de Vries, W. T. van der Graaf, D. V. van Veldhuisen, 2005, Anticancer research.

Nutrient availability in Corsican pine stands in the Netherlands and the occurrence of Sphaeropsis sapinea: a field study.

J. Roelofs, H. V. Dijk, P. Perik, 1992 .

Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

E. D. de Vries, E. de Vries, J. Kosterink, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity.

E. D. de Vries, T. Suter, J. Gietema, 2007, European journal of cancer.

Serum HER2 levels are increased in patients with chronic heart failure

D. J. Veldhuisen, J. Gietema, D. Sleijfer, 2007, European journal of heart failure.

Biodistribution and pharmacokinetics of radiolabeled trastuzumab in HER2-positive metastatic breast cancer

D. J. Veldhuisen, J. Kosterink, J. Gietema, 2004 .

The dilemma of the strive for apoptosis in oncology: mind the heart.

E. D. de Vries, J. Gietema, D. V. van Veldhuisen, 2005, Critical reviews in oncology/hematology.

Cardiotoxicity after anticancer treatment

P. Perik, 2005 .

Cardiovascular toxicity caused by cancer treatment: strategies for early detection.

E. D. de Vries, J. Gietema, D. V. van Veldhuisen, 2009, The Lancet. Oncology.

Measurement of coronary calcium scores by electron beam computed tomography or exercise testing as initial diagnostic tool in low-risk patients with suspected coronary artery disease

M. Oudkerk, R. Vliegenthart, M. Götte, 2007, European Radiology.

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients

E. D. de Vries, J. Gietema, D. V. van Veldhuisen, 2007, Expert review of anticancer therapy.

Petiole elongation inRumex species during submergence and ethylene exposure: The relative contributions of cell division and cell expansion

L. Voesenek, C. Blom, P. Perik, 1990, Journal of Plant Growth Regulation.

Between-centre differences in care for in-hospital cardiac arrest: a prospective cohort study

M. Schluep, H. Endeman, B. Gravesteijn, 2021, Critical Care.

111In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment

E. D. de Vries, A. Brouwers, J. de Jong, 2014, Molecular imaging.

111In-Trastuzumab Scintigraphy in HER2-Positive Metastatic Breast Cancer Patients Remains Feasible during Trastuzumab Treatment.

E. D. de Vries, A. Brouwers, J. de Jong, 2014, Molecular imaging.

Morphological aspects of petiole elongation in submerged Rumex species

L. Voesenek, C. Blom, P. Perik, 1989 .

Long-term survival and health-related quality of life after in-hospital cardiac arrest.

M. Schluep, C. Kuijs, M. Blans, 2021, Resuscitation.

Cardiotoxicity after anticancer treatment

D. Sleijfer, D. V. Veldhuisen, P. Perik, 2005 .

Natriuretic peptides in anthracycline‐induced cardiotoxicity

D. J. Veldhuisen, J. Gietema, P. Perik, 2005, European journal of heart failure.